Clinical Trials Browser

Melanoma × obatoclax × Dermatologic × Clear all

NCT00724841 2016-07-22

A Phase I/II Study of GMX1777 in Combination With Temozolomide for the Treatment of Metastatic Melanoma

Phase 1/2 Terminated

Melanoma